Phase III study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based chemotherapy (study L00070 IN 30
Phase III study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based chemotherapy (study L00070 IN 30
Phase III study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based chemotherapy (study L00070 IN 309 F0)
Status
Status :
Completed
Type of study
Phase III
Min. Age
18
Years old
Max. Age
80
Years old
Gender
All
Therapeutic area :
Oncology
Disease :
Squamous cell carcinoma
Study medication :
Vinflunine (Javlor®)
Phase :
Phase III
Start Date :
02 April 2012
End date :
23 November 2018
Study ID :
L00070 IN 309 F0
EudraCT/CTIS number :
2011-005081-38
CT.gov Number :
NCT02347332
Send by email